AFFINISOL: Pharmabiz.com  
 
 
 
       
  Editorial
 A BAD YEAR FOR TOP MNCs   
 Wednesday, March 25, 2015 
 Top global pharmaceutical companies are struggling to maintain their high profits and sales growth in the face of strong generic competition and poor research productivity. 
  Past Editorial...  
TODAY'S NEWS
12:00  [IST]EMA recommends marketing authorisation for Lenvima to treat adults with thyroid cancer
11:00  [IST]BDSI's phase 3 study of Clonidine topical gel to treat painful diabetic neuropathy fails to meet primary endpoint
10:00  [IST]CHMP recommends approval of empagliflozin/metformin to treat type 2 diabetes
09:00  [IST]Novartis inks pact with Aduro Biotech to develop next generation cancer immunotherapies
more news >>
TOP NEWS
08:00  [IST]Swadeshi Jagaran Manch asks govt to reconstitute IPR Think Tank to remove conflict of interest
08:00  [IST]National Bio-Diversity Authority gives wake up call to state boards to comply with ABS notification
08:00  [IST]Researchers at Global Homoeopathy Foundation develop new homoeopathic drug for TB
08:00  [IST]US FDA issues draft guidance on cGMP for combination products, invites comments by May end
08:00  [IST]Special squads of drug inspectors formed in TN to prevent sale of ‘oseltamivir’ without prescription
08:00  [IST]DTAB to consult ICMR for including stem cell & cell based products under definition of new drug
more news >>
YESTERDAY'S NEWS
18:00  [IST]Fujifilm to buy Cellular Dynamics International for $307 million
17:00  [IST]HBM Partners acquires minority stake in APR Applied Pharma Research
16:00  [IST]Schott trained more than 3,000 pharma professionals through the Fiolax Academy
15:00  [IST]US FDA approves Emergent BioSolutions' Anthrasil to treat inhalational anthrax
14:45  [IST]Strides to launch generic drug sofosbuvir in India under brand name 'Virso' to treat hepatitis C
14:00  [IST]DKSH transfers two China pharma brands, Combizym & Hirudoid to CMS
more news >>
INTERVIEW  
Life sciences an important industry for Information Technology companies
Ramesh J. Chougule, Associate Vice President, Life Sciences and Services, Infosys, tells Nandita Vijay
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent decision to ban polyethylene terephthalate (PET) bottles as primary packaging material in pharmaceutical industry justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2015 Saffron Media Pvt. Ltd |